20 September 2018
The Russian Federal Service for Intellectual Property (Rospatent) published a document on amendments to the Rules for drawing up, filing and reviewing documents that are the basis for committing legally significant actions for the state registration of inventions and their forms and Requirements to the documents for an application for grant of a patent for an invention approved by Order of the Ministry of Economic Development of the Russian Federation of 25 May 2016 No. 316.
In the practice of patenting inventions in pharmaceutics, there are inventions that can be categorized as ‘ever greening patents’ if, by this definition, the presumably the same pharmaceutical compositions are understood, but characterized by other features not known from the art.
Such pharmaceutical compositions differ from those known by one or more features, for example, such as:
The essence of the changes introduced is to limit the use of such features when characterizing the pharmaceutical composition in the claims.
The above characteristics according to the changes are not taken into account when assessing patentability for compliance with the condition of patentability “novelty” or “inventive level”. The proposed approach will help avoiding the “double” patenting of already known compositions or their application.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024